Asset Publisher

TESFAM

Scaling up HIV Counseling & Testing Services within a Health Demographic Surveillance System in Manhiça, Mozambique

Duration
2011-2017
Coordinator
Denise Naniche
Funded by
Centers for Disease Control in Atlanta -Pepfar

The world is moving towards HIV testing and immediate antiretroviral therapy for all. In many areas such as Sub Saharan Africa where HIV prevalence is high, this does not only mean ensuring access to medicines but also calls for attention to each step in the continuum of care. Prior to implementation of test and start, several questions need to be addressed in the communities:

  1. What are the most adapted HIV testing strategies for community needs?
  2. What is the extent of loss to follow up after initiation of treatment?
  3. What are the barriers at each step of the continuum.

The overarching goal of TESFAM  is to increase linkage to HIV care and treatment services after HIV testing  in the community of Manhiça, a semi-rural district in Southern Mozambique.

TESFAM is a collaborative project between ISGLOBAL and the CISM (Centro de Investigação em Saúde da Manhiça), a leading African HIV research center, in alliance with  Fundação Ariel Glaser contra o SIDA Pediátrico.

The project aims to assess different HIV testing and counseling approaches (voluntary testing, home based testing and provider initiated testing) in terms of their rates of linkage and retention in care as well as cost effectiveness.

In the context of tesfam, more than 10,000 homes have been visited by community health workers and a total of 15.000 people have received HIV counseling and testing in one of the three testing modalities.

The tesfam project will shed light on the specifics of care-seeking behavior for HIV care and pave the way for optimizing HIV testing and linkage strategies to close the gaps in the cascade of HIV care.

Our Team

Principal Investigator (PI)

  • Denise Suzanne Naniche
    Denise Suzanne Naniche

ISGlobal Team

Other projects

See Past Projects

COMBACTE

Combating Bacterial Resistance In Europe

GAMA

Development of Novel Gastrointestinal Biomarkers for Use in HIV Incidence Determination in a Sub-Saharan African Setting

COMBACTE-CARE

Combatting Bacterial Resistance in Europe - Carbapenem Resistance

MAMAH

Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women

INTE-AFRICA

Integrating and decentralizing diabetes and hypertension services in Africa

ICARIA

Improving Care through Azithromycin Research for Infants in Africa

PreFIT

Predicting the Future: Incipient Tuberculosis

ANTICOV

Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19

Stool4TB

Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV

TB-RECONNECT

Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status

SToolNIH

Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring

END-VOC

ENDing COVID-19 Variants Of concern through Cohort studies (END-VOC)

TwinAir

Digital Twins Enabled Indoor Air Quality Management for Healthy Living

ENDÈMIC

Community knowledge generation through scientific culture, urban ecology and art

EpiGen

Building Scalable Pathogen Genomic Epidemiology in Ethiopia

Hepatitis C Free Baleares

Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.